arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CYPHERPUNK TECHNOLOGIES INC.

CYPH
$3.64 ▼ -0.10 (-2.67%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
43 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Neutral
auto_awesome

Analytical Summary

CYPHERPUNK TECHNOLOGIES INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $671.0M
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -3.2%
FCF / Share $-0.01
Trailing P/E 17.3x
Price / Book 2.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$375.00K
— 0.0%
Net Income Profit after all expenses
$39.39M
↑ +151.0%
FCF / Share Free cash flow per share
$-0.01
↑ +28.4%

Health Breakdown

Returns
50
Cash Quality
2

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 43 quarters